Evidence map›Paper›PMID 34360659›Full record

ReviewInternational journal of molecular sciences2021

Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword.

Théo Ebermeyer, Fabrice Cognasse, Philippe Berthelot, Patrick Mismetti, Olivier Garraud, Hind Hamzeh-Cognasse

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. European journal of nuclear medicine and molecular imaging · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Targeting platelet-tumor cell interactions: a novel approach to cancer therapy.Medical oncology (Northwood, London, England) · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Immunity and Coagulation in COVID-19.International journal of molecular sciences · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Théo EbermeyerINSERM U1059-SAINBIOSE, Université de Lyon, F-42023 Saint-Etienne, France.
Fabrice CognasseINSERM U1059-SAINBIOSE, Université de Lyon, F-42023 Saint-Etienne, France.
Philippe BerthelotTeam GIMAP, CIRI-Centre International de Recherche en Infectiologie, Université de Lyon, U1111, UMR5308, F-69007 Lyon, France.
Patrick MismettiINSERM U1059-SAINBIOSE, Université de Lyon, F-42023 Saint-Etienne, France.
Olivier GarraudINSERM U1059-SAINBIOSE, Université de Lyon, F-42023 Saint-Etienne, France.ORCID 0000-0002-4102-3714
Hind Hamzeh-CognasseINSERM U1059-SAINBIOSE, Université de Lyon, F-42023 Saint-Etienne, France.ORCID 0000-0003-1462-3893

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelets are hematopoietic cells whose main function has for a long time been considered to be the maintenance of vascular integrity. They have an essential role in the hemostatic response, but they also have functional capabilities that go far beyond it. This review will provide an overview of platelet functions. Indeed, stress signals may induce platelet apoptosis through proapoptotis or hemostasis receptors, necrosis, and even autophagy. Platelets also interact with immune cells and modulate immune responses in terms of activation, maturation, recruitment and cytokine secretion. This review will also show that platelets, thanks to their wide range of innate immune receptors, and in particular toll-like receptors, and can be considered sentinels actively participating in the immuno-surveillance of the body. We will discuss the diversity of platelet responses following the engagement of these receptors as well as the signaling pathways involved. Finally, we will show that while platelets contribute significantly, via their TLRs, to immune response and inflammation, these receptors also participate in the pathophysiological processes associated with various pathogens and diseases, including cancer and atherosclerosis.

Indexed as

Platelet ActivationAnimalsAtherosclerosisBlood PlateletsHumansImmunity, InnateNeoplasmsReceptors, ImmunologicToll-Like ReceptorsReceptors, ImmunologicToll-Like Receptorsimmunomodulatory moleculesimmuno-surveillanceinflammationpathophysiologytoll-like receptor

Identifiers

PMID34360659
PMCPMC8347377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.